eXaUC/CD, Exagen's exclusive blood test for differentiating Ulcerative Colitis from Crohn's Disease, is now available for direct physician ordering. With a 90% accuracy, it is designed for use on patients that have an established diagnosis of IBD using a combination of laboratory tests such as eXaIBD, clinical workup, and/or scoping procedures. Created through our proprietary discovery engine Coperna, the test is based on expression levels of genes selected for their diagnostic accuracy in differentiating UC from CD. Our laboratory process measures the messenger RNA from white blood cells and reflects the activity of the genes. Please contact Exagen ClientServices (866-392-4361) for more infomation.